| Amy Leigh Stark, MD | |
|
1400 Wallace Blvd, Amarillo, TX 79106-1708 | |
| (806) 414-9970 | |
| (806) 351-3783 |
| Full Name | Amy Leigh Stark |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 11 Years |
| Location | 1400 Wallace Blvd, Amarillo, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376988378 | NPI | - | NPPES |
| 94677794 | Medicaid | NM | |
| 387244201 | Medicaid | TX |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Tech University Health Sciences Center Amarillo | 9234037847 | 71 |
News Archive
Mentor Capital, Inc.'s first funding tranche to extend its investment in its proprietary Cancer Immunotherapy Index closes today. Cash investment from 1,400 existing shareholders projects to be approximately 20% oversubscribed from target. Company management reservation to fund will be correspondingly reduced to remain within the $1.2 Million seed funding limit. Already authorized follow-on public funding tranches total an additional $125 Million that will also be targeted for investment into the best of the Cancer Immunotherapy Index companies.
Shawnee County, Kan., District Court Judge Richard Anderson - who permitted Kansas Attorney General Phill Kline (R) to view edited medical records of 90 women and girls who underwent late-term abortions - on Monday filed a response with the state Supreme Court asking that some information about the case be kept confidential, the AP/Kansas City Star reports.
A recent Mayo Clinic study found that people with chronic obstructive pulmonary disease (COPD) are about twice as likely to develop mild cognitive impairment (MCI) - and chances are that it will include memory loss. The study was recently published in Mayo Clinic Proceedings.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
A new study has identified important factors that can improve the transfer of patients from the intensive care unit to a general hospital ward, a high-risk transition in which breakdowns in communication, medical errors and adverse events resulting in readmission can occur.
› Verified 6 days ago
| Entity Name | Texas Tech University Health Sciences Center Amarillo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013942150 PECOS PAC ID: 9234037847 Enrollment ID: O20031220000051 |
News Archive
Mentor Capital, Inc.'s first funding tranche to extend its investment in its proprietary Cancer Immunotherapy Index closes today. Cash investment from 1,400 existing shareholders projects to be approximately 20% oversubscribed from target. Company management reservation to fund will be correspondingly reduced to remain within the $1.2 Million seed funding limit. Already authorized follow-on public funding tranches total an additional $125 Million that will also be targeted for investment into the best of the Cancer Immunotherapy Index companies.
Shawnee County, Kan., District Court Judge Richard Anderson - who permitted Kansas Attorney General Phill Kline (R) to view edited medical records of 90 women and girls who underwent late-term abortions - on Monday filed a response with the state Supreme Court asking that some information about the case be kept confidential, the AP/Kansas City Star reports.
A recent Mayo Clinic study found that people with chronic obstructive pulmonary disease (COPD) are about twice as likely to develop mild cognitive impairment (MCI) - and chances are that it will include memory loss. The study was recently published in Mayo Clinic Proceedings.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
A new study has identified important factors that can improve the transfer of patients from the intensive care unit to a general hospital ward, a high-risk transition in which breakdowns in communication, medical errors and adverse events resulting in readmission can occur.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Leigh Stark, MD 1400 Wallace Blvd, Amarillo, TX 79106-1708 Ph: (806) 414-9970 | Amy Leigh Stark, MD 1400 Wallace Blvd, Amarillo, TX 79106-1708 Ph: (806) 414-9970 |
News Archive
Mentor Capital, Inc.'s first funding tranche to extend its investment in its proprietary Cancer Immunotherapy Index closes today. Cash investment from 1,400 existing shareholders projects to be approximately 20% oversubscribed from target. Company management reservation to fund will be correspondingly reduced to remain within the $1.2 Million seed funding limit. Already authorized follow-on public funding tranches total an additional $125 Million that will also be targeted for investment into the best of the Cancer Immunotherapy Index companies.
Shawnee County, Kan., District Court Judge Richard Anderson - who permitted Kansas Attorney General Phill Kline (R) to view edited medical records of 90 women and girls who underwent late-term abortions - on Monday filed a response with the state Supreme Court asking that some information about the case be kept confidential, the AP/Kansas City Star reports.
A recent Mayo Clinic study found that people with chronic obstructive pulmonary disease (COPD) are about twice as likely to develop mild cognitive impairment (MCI) - and chances are that it will include memory loss. The study was recently published in Mayo Clinic Proceedings.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.
A new study has identified important factors that can improve the transfer of patients from the intensive care unit to a general hospital ward, a high-risk transition in which breakdowns in communication, medical errors and adverse events resulting in readmission can occur.
› Verified 6 days ago
Dr. W Mitchell Jones Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2319 Judy Street, Amarillo, TX 79106 Phone: 806-355-0437 | |
Dr. Ruby D Saulog, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1731 Hagy Blvd, Amarillo, TX 79106 Phone: 877-664-6669 Fax: 716-325-9094 | |
Dr. Olga Maria Tolscik, M.D., MPH Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7620 Wallace Boulevard, Amarillo, TX 79124 Phone: 806-359-5468 | |
Dr. Que Vu Nguyen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-355-9703 | |
Dr. Mary Lou Montgomery, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-355-9703 | |
Kathryn Elaine Mcneil, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1215 S Coulter St Ste 204, Amarillo, TX 79106 Phone: 806-677-2039 Fax: 806-677-2024 | |
Ruth Elizabeth Grant, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1900 S Coulter St Ste A, Amarillo, TX 79106 Phone: 806-677-7610 Fax: 806-356-0045 |